Dr. Jean Jacques Kiladjian ASH 2018 Research Studies

[PVReporter]

Ropeg 3 yr follow-up vs HU, MPNs in patients under age of 25 at diagnosis, Targeting JAK2 mutation with IFN and Arsenic, see interview here - bit.ly/2Sa0aES

Happy Holidays,

David Wallace - PV Reporter

[Wyebird]

Thank you so much. A lot of information. Easy to understand, so much is being learnt about MPNs. Promising

[PVReporter]

Your very welcome. I think the environment is promising too!

[Bluetop]

Significant change re Ropeg. Thanks for posting

[EleanorPV]

Wow more exciting research ahead